Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis

Cellular and Molecular Life Sciences

Volumn 53, Issue 6, 1997, Pages 527-532

  Reutelingsperger, C P M ^a   Van Heerde, W L ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b INSERM   (France)

Author keywords

Annexin V; Apoptosis; Coagulation; Inflammation; Phosphatidylserine

Indexed keywords

CELL SURFACE PROTEIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PHOSPHOLIPID BINDING PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CELL TYPE; ETIOLOGY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PROTEIN LOCALIZATION;

ANIMALS; ANNEXIN A5; APOPTOSIS; BLOOD COAGULATION; HUMANS; INFLAMMATION; MEMBRANES, ARTIFICIAL; PHOSPHATIDYLSERINES;

ANIMALIA;

EID: 0030858046     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050067     Document Type: Article

References (58)

1. Raynal P. and Pollard H. B. (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta 1197: 63-93
2. Seaton B. A. (ed.) (1996) Annexins: molecular structure to cellular function. Book series: Molecular Biology Intelligence Unit, R. G. Landes Company, Austin, USA
3. Van Heerde W. L., Degroot P. G. and Reutelingsperger C. P. M. (1995) The complexity of the phospholipid binding protein annexin V. Thromb. Haemost. 73: 172-179
4. Reutelingsperger C. P. M., Hornstra G. and Hemker H. C. (1985) Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur. J. Biochem. 151: 625-629
5. Tait J. F., Gibson D. and Fujikawa K. (1989) Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J. Biol. Chem. 264: 7944-7949
6. Andree H. A., Reutelingsperger C. P. M., Hauptmann R., Hemker H. C., Hermens W. T. and Willems G. M. (1990) Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J. Biol. Chem. 265: 4923-4928
7. Blackwood R. A. and Ernst J. D. (1990) Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem. J. 266: 195-200
8. Meers P., Daleke D., Hong K. and Papahadjopoulos D. (1991) Interactions of annexins with membrane phospholipids. Biochemistry 30: 2903-2908
9. Tait J. F. and Gibson D. (1992) Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Arch. Biochem. Biophys. 298: 187-191
10. 2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nature Structural Biology 2: 968-974
11. 2+-dependent phospholipid binding and phosphorylation of lipocortin I. J. Biol. Chem. 262: 6931-6937
12. Mosser G., Ravanat C., Freyssinet J. M. and Brisson A. (1991) Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J. Molec. Biol. 217: 241-245
13. Andree H. A., Stuart M. C., Hermens W. T., Reutelingsperger C. P. M., Hemker H. C., Frederik P. M. et al. (1992) Clustering of lipid-bound annexin V may explain its anticoagulant effect. J. Biol. Chem. 267: 17907-17912
14. Meers P. and Mealy T. (1993) Calcium-dependent annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative charge. Biochemistry 32: 11711-11721
15. Seigneuret M. and Devaux P. F. (1984) ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape change. Proc. Natl Acad. Sci. USA 81: 3751-3755
16. Diaz C. and Schroit A. J. (1996) Role of translocases in the generation of phosphatidylserine asymmetry. J. Membr. Biol. 151: 1-9
17. Zwaal R. F. A. and Schroit A. J. (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132
18. Bevers E. M., Comfurius P., van Rijn J. L. M. L., Hemker H. C. and Zwaal R. F. A. (1982) Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur. J. Biochem. 122: 429-436
19. Bevers E. M., Comfurius P. and Zwaal R. F. A. (1983) Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta 736: 57-66
20. Williamson P., Bevers E. M., Smeets E. F., Comfurius P., Schlegel R. A. and Zwaal R. F. A. (1995) Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 34: 10448-10455
21. Connor J., Pak C. C. and Schroit A. J. (1994) Exposure of phosphatidylserine in the outer leaflet of human red cells. Relationship to cell density, cell age and clearance by mononuclear cells. J. Biol. Chem. 269: 2399-2404
22. Fadok V. A., Voelker D. R., Campbell P. A., Cohen J. J., Bratton D. L. and Henson P. M. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207-2216
23. Verhoven B., Schlegel R. A. and Williamson P. (1995) Mechanism of phosphatidylserine exposure, a phagocyte recognition signal on apoptotic T lymphocytes. J. Expl Med. 182: 1597-1601
24. Rosing J., Van Rijn J. L. M. L., Bever E. M., Van Dieijen G., Comfurius P. and Zwaal R. F. A. (1985) The role of activated human platelets in prothrombin and factor X activation. Blood 65: 319-332
25. Esmon C. T. (1993) Cell mediated events that control blood coagulation and vascular injury. Ann. Rev. Cell Biol. 9: 1-26
26. Rosing J., Bevers E. M., Comfurius P., Hemker H. C., Van Dieijen G., Weiss H. J. et al. (1985) Impaired factor X and prothrombin activation associated with a decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood 65: 1557-1561
27. Weiss H. J. (1994) Scott syndrome: a disorder of platelet coagulant activity. Semin. Hematol 31: 312-319
28. Schroit A. J., Madsen, J. W. and Tanaka Y. (1985) In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J. Biol. Chem. 260: 5131-5138
29. Connor J., Bucana C., Fidler I. J. and Schroit A. J. (1989) Differentiation dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer leaflet lipid by prothrombinase complex formation. Proc. Natl Acad. Sci. USA 86: 3184-3188
30. Savill J. (1995) The innate immune system: recognition of apoptotic cells. In: Apoptosis and the Immune Response, pp. 341-369, Gregory C. D. (ed.), Wiley-Liss Inc, New York
31. Thompson C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1465-1462
32. Kroemer G., Petit P. X., Zamzami N., Vayssiere J.-L. and Mignotte B. (1995) The biochemistry of apoptosis. FASEB J. 9: 1277-1287
33. Martin S. J. and Green D. R. (1995) Protease activation during apoptosis: death by a thousand cuts. Cell 82: 349-352
34. Susin S. A., Zamzami N. and Kroemer G. (1996) The cell biology of apoptosis: evidence for the implication of mitochondria. Apoptosis 1: 231-242
35. Thiagarajan P. and Tait J. F. (1990) Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J. Biol. Chem. 265: 17420-17423
36. Rao L. V., Tait J. F. and Hoang A. D. (1992) Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa tissue factor activity and prothrombinase activity. Thromb. Res. 67: 517-531
37. Koopman G., Reutelingsperger C. P. M., Kuijten G. A. M., Keehnen R. M. J., Pals S. T. and Vanoers M. H. J. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420
38. Homburg C. H. E., Dehaas M., Vondemborne A. E. G. K., Verhoeven A. J., Reutelingsperger C. P. M. and Roos D. (1995) Human neutrophils lose their surface Fc gamma RIII and acquire annexin V binding sites durig apoptosis in vitro. Blood 85: 532-540
39. Vermes I., Hannen C., Steffens-Nakken H. and Reutelingsperger C. P. M. (1995) A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184: 39-52
40. Martin S. J., Reutelingsperger C. P. M., McGahon A. J., Rader J., van Schie C. A. A., LaFace D. M. et al. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Expl Med. 182: 1545-1557
41. Martin S. J., Reutelingsperger C. P. M. and Green D. R. Annexin V, a specific probe for apoptotic cells. In: Techniques in Apoptosis. A User's Guide, pp. 107-120, Cotter T. G. and Martin S. J. (eds), Portland Press Ltd, London
42. Castedo M., Hirsch T., Susin S. A., Zumzami N., Marchetti P., Macho A, et al. (1996) Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol. 157: 512-521
43. Susin S. A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A, et al. (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protein. J. Expl Med. 184: 1331-1341
44. Martin S. J., Finucane D. M., Amarantemendes G. P., Obrien G. A. and Green D. R. (1996) Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271: 28753-28756
45. Van Engeland M., Ramaekers F. C. S., Schutte B. and Reutelingsperger C. P. M. (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24: 131-139
46. Bennett M. R., Gibson D. F., Schwartz S. M. and Tait J. F. (1995) Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circulation Res. 77: 1136-1142
47. van den Eijnde S. M., Boshart L., Reutelingsperger C. P. M., De Zeeuw C. I. and Vermeij-Keers C. (1997) Phosphatidylserinc plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Diff. In press
48. O'Brien I., Reutelingsperger C. P. M. and Holdaway K. (1997) The use of Annexin V and TUNEL to monitor the progression of apoptosis in plants. Cytometry. In press
49. Flaherty M. J., West S., Heimark R. L., Fujikawa K. and Tait J. F. (1990) Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system. J. Lab. Clin. Med. 115: 174-181
50. Romisch J., Schuler E., Bastian B., Burger T., Dunkel F. G., Schwinn A, et al. (1992) Annexins I to VI: quantitative determination in different human cell types and in plasma alter myocardial infarction. Blood Coag. Fibrinol. 3: 11-17
51. Christmas P., Callaway J., Fallon J., Jones J. and Haigler H. T. (1991) Selective secretion of annexin I, a protein without a signal sequence, by the human prostate gland. J. Biol. Chem. 266: 2499-2507
52. Koster J. J., Boustead C. M., Middleton C. A. and Walker J. H. (1993) The sub-cellular localization of annexin V in cultured chick-embryo fibroblasts. Biochem. J. 291: 595-600
53. Solito E., Raugei G., Melli M. and Parente L. (1991) Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FFBS Lett. 291: 238-244
54. Thiagarajan P. and Tait J. F. (1991) Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J. Biol. Chem. 266: 24302-24307
55. Vanheerde W. L., Poort S., Vantveer C., Reutelingsperger C. P. M. and Degroot P. G. (1994) Binding of recombinant annexin V to endothelial cells: Effect of annexin V binding on endothelial-cell-mediated thrombin formation. Biochem. J. 302: 305-312
56. Sugimura M., Donato R., Kakkar V. V. and Scully M. F. (1994) Annexin-V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces. Blood Coag. Fibrinol. 5: 365-373
57. Casciola-Rosen L., Rosen A., Petri M. and Schlissel M. (1996) Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 93: 1624-1629
58. Holmgren L., O'Reilly M. S. and Folkman J. (1995) Dormancy of micrometastasis: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1: 149-153